Stock 3320 CHINA RESOURCES PHARMACEUTICAL GROUP LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Other languages China Resources Pharmaceutical Group Limited

Equities

3320

HK0000311099

Delayed Hong Kong S.E.
Other stock markets
 04:37:11 09/05/2024 BST 		5-day change 1st Jan Change
5.5 HKD +3.97% Intraday chart for China Resources Pharmaceutical Group Limited +8.48% +7.21%
04-24 China Resources Pharmaceutical Group Limited Announces Change of Company Secretary CI
04-18 China Resources Pharma Unit Issues 3 Billion Yuan Bonds MT

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
China Resources Pharmaceutical Group Limited Announces Change of Company Secretary
China Resources Dong-E-E-Jiao Company Limited Provides Earnings Guidance for the Three Months Ended 31 March 2024
China Resources Pharmaceutical Posts Gains in Full Year 2023 Profit
China Resources Pharmaceutical Group Limited Proposes Final Dividend for the Year Ended 31 December 2023, Payable on 19 July 2024
China Resources Pharmaceutical Group Limited Reports Earnings Results for the Full Year Ended December 31, 2023
CR Boya Bio-Pharmaceutical's 2023 Profit Falls on Lower Revenue
CR Sanjiu Expects Increase in 2023 Profit
China Resources Pharmaceutical Group Limited Announces Management Changes, Effective on 27 December 2023
Dong-E-E-Jiao's Nine-Moth Profit Rises on Higher Revenue
CR Boya Bio-Pharmaceutical's January-September Profit Increases
Dong-E-E-Jiao Expects January-September Attributable Profit to Rise Up to 60%
China Resources Pharma's Profit Marginally Rises in H1
China Resources Pharmaceutical Group Limited Reports Earnings Results for the Half Year Ended June 30, 2023
CR Sanjiu Medical & Pharmaceutical's H1 Attributable Profit Rises 31%
KPC Pharmaceuticals' Attributable Profit Rises 3.1%; Shares Slip 4%
China Resources Pharmaceutical's Subsidiaries Log Increases in H1 Profits
China Resources Boya's H1 Attributable Profit Jumps 16.9%
Dong-E-E-Jiao's H1 Attributable Profit Surges 72%
China Resources Pharmaceutical Group Limited Provides Earnings Guidance for the Six Months Ended 30 June 2023
China Resources Pharmaceutical Group Limited Announces Board and Executive Changes
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 3320 Stock
  4. News China Resources Pharmaceutical Group Limited
  5. Other languages